PortfoliosLab logo

ADMA Biologics, Inc. (ADMA)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS0008991046
CUSIP000899104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.14
Year Range$1.09 - $2.31
EMA (50)$2.09
EMA (200)$1.77
Average Volume$2.59M
Market Capitalization$420.19M

ADMAShare Price Chart


Chart placeholderClick Calculate to get results

ADMAPerformance

The chart shows the growth of $10,000 invested in ADMA Biologics, Inc. in Oct 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,548 for a total return of roughly -74.52%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%MarchAprilMayJuneJulyAugust
28.17%
-9.63%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.47%8.19%
6M38.96%-7.42%
YTD51.77%-13.03%
1Y41.72%-5.85%
5Y-8.58%10.86%
10Y-14.64%9.89%

ADMAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20222.84%11.03%13.66%0.55%11.41%-3.41%8.08%-0.00%
202113.85%4.05%-23.81%11.36%-10.71%-8.57%-3.13%-13.55%-15.67%14.16%6.98%2.17%
2020-1.00%-26.39%-1.20%2.43%11.53%-10.94%21.84%-28.57%-6.27%-16.74%2.51%-4.41%
201923.43%38.64%-7.33%22.16%-10.37%-6.75%-6.46%23.76%-0.67%9.89%-2.86%-15.79%
201815.89%0.81%22.67%8.04%9.05%-16.79%44.57%-1.99%-2.82%-13.53%-1.86%-54.65%
2017-0.20%-8.61%4.50%-7.58%-17.96%0.00%-6.76%-0.00%-10.72%-24.03%23.93%10.69%
2016-25.22%-21.29%70.32%-15.45%13.30%-23.23%31.93%-27.26%26.80%-22.93%-0.72%-7.58%
2015-3.31%-11.67%2.73%-14.18%1.78%8.18%0.65%-0.97%-9.43%9.81%-0.00%-12.09%
201410.26%-1.05%-1.88%-7.19%12.90%11.43%1.54%-5.56%10.16%14.08%5.28%-9.70%
2013-1.19%-3.61%-2.50%

ADMASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ADMA Biologics, Inc. Sharpe ratio is 0.53. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00MarchAprilMayJuneJulyAugust
0.53
-0.31
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMADividend History


ADMA Biologics, Inc. doesn't pay dividends

ADMADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-82.87%
-13.58%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMAWorst Drawdowns

The table below shows the maximum drawdowns of the ADMA Biologics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ADMA Biologics, Inc. is 91.27%, recorded on Oct 11, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.27%Nov 26, 20141727Oct 11, 2021
-20.47%Nov 19, 201324Dec 23, 201316Jan 27, 201440
-18.89%Mar 4, 201440May 12, 201412Jun 3, 201452
-12.38%Jul 10, 201433Aug 27, 201425Oct 2, 201458
-6.81%Oct 7, 20141Oct 7, 20145Oct 14, 20146
-6.78%Jan 28, 20145Feb 3, 201419Mar 3, 201424
-6.53%Jun 23, 20142Jun 24, 20147Jul 7, 20149
-6.47%Oct 29, 201311Nov 12, 20134Nov 18, 201315
-5.54%Nov 12, 20148Nov 21, 20142Nov 25, 201410
-4.21%Jun 4, 20146Jun 13, 20141Jun 17, 20147

ADMAVolatility Chart

Current ADMA Biologics, Inc. volatility is 40.22%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
40.22%
19.67%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)